Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On Today I.E. 08Th March, 2024

Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 8th March , 2024, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020 has considered and approved the following businesses:- a) Raising of funds for an aggregate amount not exceeding Rs. 800 Crore (Rupees Eight Hundred Crore only) in one or more tranches, through permissible mode(s) and / or combination(s) thereof as may be considered appropriate, by way of raising of debts, issuance of any instruments or securities, through private placement, preferential issue, rights issue, qualified institutions placement or such other methods or combinations thereof as may be decided by the Board, subject to such approvals as may be required.
08-03-2024
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

Pursuant to Regulation 29(1)(d) of the SEBI(LODR) Regulations, 2015, meeting of Board of Directors of the Company is scheduled to be held on Friday, March 8, 2024 at 10.00 am through video-conferencing in accordance with the SEBI(PIT) Regulations, 2015 and the Company,s code of conduct for prevention of Insider Trading, the Trading Window for the dealing in Company,s Securities will be closed from the date of this intimation and will open 48 hours after the conclusion of Board Meeting.
04-03-2024
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Prior Intimation Under Regulation 29(1)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Notice Of Closure Of Trading Window Under Regulation 9 Of The SEBI(Prohibition Of Insider Trading) Regulations, 2015.

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the board of directors (the "Board") of the Poly Medicure Limited (the "Company") is scheduled to be held on Friday, March 8, 2024 at 10:00 a.m. through video - conferencing facility to inter alia consider the following:- a) Business Plan for Financial Year 2024-25. b) consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s) and / or combination(s) thereof as may be considered appropriate, by way of raising of debts, issuance of any instruments or securities, through private placement, preferential issue, rights issue, qualified institutions placement or such other methods or combinations thereof as may be decided by the Board, subject to such approvals as may be required, and to transact other businesses with the permission of the Chairperson.
04-03-2024

Lighthouse Advisors Sells Poly Medicure Shares For Rs 200 Crore

According to the bulk deal data available with the BSE, Lighthouse India III Equity Investors disposed of 12,90,939 shares, amounting to a 1.3% stake in Poly Medicure.
22-02-2024
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In continuation od earlier intimation given on 31st January, 2024, pursuant to the provisions of Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 10(c) of SEBI(Share Based Employee Benefits and Sweat Equity) Regulations, 2021, as amended, please note that the Nomination and Remuneration Committee of the Board of Directors on 31st January, 2024 allotted 26,375 equity shares of face value of Rs. 5/- each exercised under Employee Stock Option Plan 2020(ESOS 2020).
14-02-2024
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submit Transcript of the Investor Meet/Call held on 02nd February, 2024 at 04:00 P.M(IST) on the Unaudited Financial Results of the Company for the quarter ended 31st December, 2023 on Standalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 31st January, 2024.
09-02-2024

Poly Medicure Q3 Results Review - 20% Plus Growth Guidance For FY25: Systematix

The domestic business, which contributes around ~1/3rd of the total revenue has grown by ~18% slightly lower than expectation (22-23%).
06-02-2024
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Friday, February 02, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended December 31, 2023 , is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/02/ICI3420240202151273.mp3
03-02-2024
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, 2nd February, 2024 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 31st December, 2023. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.
03-02-2024

Poly Medicure Q3 FY24 Results Live: profit rise by 30.01% YOY

Poly Medicure Q3 FY24 Results Live: Revenue increased by 19.23% YoY & profit increased by 30.01% YoY
02-02-2024
Next Page
Close

Let's Open Free Demat Account